Research programme: oxapenems - Micron Research/Amura

Drug Profile

Research programme: oxapenems - Micron Research/Amura

Alternative Names: AM 119; AM 122

Latest Information Update: 28 Aug 2006

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Amura; Micron Research
  • Class
  • Mechanism of Action Beta lactamase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Bacterial infections

Most Recent Events

  • 28 Aug 2006 This programme is still in active development
  • 07 Jan 2004 This programme is still in active development
  • 18 Jun 2002 Preclinical data have been added to the drug interactions and Bacterial infections antimicrobial activity sections ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top